Literature DB >> 3350152

Physiological roles of animal succinate thiokinases. Specific association of the guanine nucleotide-linked enzyme with haem biosynthesis.

T M Jenkins1, P D Weitzman.   

Abstract

The discovery of two distinct succinate thiokinases in mammalian tissues, one (G-STK) specific for GDP/GTP and the other (A-STK) for ADP/ATP, poses the question of their differential metabolic roles. Evidence has suggested that the A-STK functions in the citric acid cycle in the direction of succinyl-CoA breakdown (and ATP formation) whereas one role of the G-STK appears to be the re-cycling of succinate to succinyl-CoA (at the expense of GTP) for the purpose of ketone body activation. A third metabolic participation of succinyl-CoA is in haem biosynthesis. This communication shows that in chemically induced hepatic porphyria, when the demand for succinyl-CoA is increased, it is the level of G-STK only which is elevated, that of A-STK being unaffected. The results implicate G-STK in the provision of succinyl-CoA for haem biosynthesis, a conclusion which is further supported by the observation of a high G-STK/A-STK ratio in bone marrow.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3350152     DOI: 10.1016/0014-5793(88)80629-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Anaerobic growth defects resulting from gene fusions affecting succinyl-CoA synthetase in Escherichia coli K12.

Authors:  F Mat-Jan; C R Williams; D P Clark
Journal:  Mol Gen Genet       Date:  1989-01

2.  Effects of acute ethanol administration on rat liver 5-aminolaevulinate synthase activity.

Authors:  A A Badawy; C J Morgan; N R Davis
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

3.  Metabolically based liver damage pathophysiology in patients with urea cycle disorders - A new hypothesis.

Authors:  Ivan Ivanovski; Miloš Ješić; Ana Ivanovski; Livia Garavelli; Petar Ivanovski
Journal:  World J Gastroenterol       Date:  2017-11-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.